Stocks Hitting 52-Week Lows

shares dipped 76.61 percent to reach a new 52-week low of $0.400 after the company announced its plans to cut jobs as its multicenter, Phase 2 Nexus clinical trial evaluating iSONEP™ in patients with wet age-related macular degeneration did not meet primary or key secondary endpoints.

shares dipped 37.12 percent to touch a new 52-week low of $3.54. EVINE Live reported FQ1 adjusted loss of $0.04 per share on revenue of $158.5 million.

shares touched a new 52-week low of $15.997 after the company reported a loss in the first quarter. The Brooklyn, New York-based company posted a quarterly net loss of $36.6 million, or $0.84 per share, versus a year-ago loss of $0.5 million, or $0.01 per share.

shares fell 3.10 percent to reach a new 52-week low of $4.06. hhgregg shares have dropped 52.71 percent over the past 52 weeks, while the S&P 500 index has gained 12.70 percent in the same period.